A synthetic peptide for use as a blocking control in assays to test for specificity of MAP4 K2 antibody, Alternative Names: MAP4K2 control peptide, MAP4K2 antibody Blocking Peptide, Anti-MAP4K2 Blocking Peptide, Mitogen-Activated Protein Kinase 2 Blocking Peptide, BL44 Blocking Peptide, GCK Blocking Peptide, RAB8IP Blocking Peptide, MAP4, MAP-4, MAP 4, MAP-4 Blocking Peptide, MAP 4 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
MAP4K2
(Mitogen-Activated Protein Kinase Kinase Kinase Kinase 2 (MAP4K2))
Hintergrund
MAP4K2 is a member of the serine/threonine protein kinase family. Although this kinase is found in many tissues, its expression in lymphoid follicles is restricted to the cells of germinal centre, where it may participate in B-cell differentiation. This kinase can be activated by TNF-alpha, and has been shown to specifically activate MAP kinases. This kinase is also found to interact with TNF receptor-associated factor 2 (TRAF2), which is involved in the activation of MAP3K1/MEKK1.